Evidence map›Paper›PMID 28663797›Full record

ArticleNew microbes and new infections2017

Identification of tigecycline- and vancomycin-resistant

M Yousefi, F Fallah, M Arshadi, M R Pourmand, A Hashemi, G Pourmand

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibiotic resistance and typing ofIranian journal of basic medical sciences · 2020
    Article
  13. Vancomycin resistantJournal of advanced research · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M YousefiInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
F FallahDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
M ArshadiDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
M R PourmandDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
A HashemiDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
G PourmandUrology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRBirjand University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

Antibiotic resistancemethicillin-resistant Staphylococcus aureustigecyclinevanA genevancomycin

Identifiers

PMID28663797
PMCPMC5479968
OpenAlexW2617073486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.